Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Autonomix MedicalAMIX -1.92%15 Future 3-5Y EPS without NRI Growth Rate is 27.63 as of Sep. 06, 2026. GuruFocus rates AMIX with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 282 Medical Devices & Instruments companies, Autonomix Medical ranks better than 65.96% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate is 27.63.
Autonomix Medical (NAS:AMIX) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Autonomix Medical Future 3-5Y EPS without NRI Growth Rate Related Terms
AMIX vs STME, ITOC, USAQ: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Autonomix Medical Future 3-5Y EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 27.63 mean?
Autonomix Medical (AMIX) has a Future 3-5Y EPS without NRI Growth Rate of 27.63 as of Sep. 06, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Autonomix Medical and its competitors. According to the industry distribution chart, Autonomix Medical ranks #96 out of 282 companies in the Medical Devices & Instruments industry, placing it in the top 34%.
Is Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate too high?
Autonomix Medical's current Future 3-5Y EPS without NRI Growth Rate is 27.63. The Medical Devices & Instruments industry median Future 3-5Y EPS without NRI Growth Rate is 20.70. Autonomix Medical's value of 27.63 is 33.5% above this industry median. Based on the distribution chart, Autonomix Medical ranks #96 out of 282 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Autonomix Medical has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Autonomix Medical's Future 3-5Y EPS without NRI Growth Rate compare to STME and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Autonomix Medical ranks #96 out of 282 companies for Future 3-5Y EPS without NRI Growth Rate. This puts Autonomix Medical in the upper half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 20.70. Autonomix Medical's value of 27.63 is 33.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median Future 3-5Y EPS without NRI Growth Rate among Medical Devices & Instruments companies is 20.70, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Autonomix Medical's current Future 3-5Y EPS without NRI Growth Rate of 27.63 is 33.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Autonomix Medical and its competitors. For the Medical Devices & Instruments industry, the median Future 3-5Y EPS without NRI Growth Rate is 20.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Autonomix Medical's current Future 3-5Y EPS without NRI Growth Rate is 27.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autonomix Medical stock overvalued right now?
Autonomix Medical (AMIX) has a current Future 3-5Y EPS without NRI Growth Rate of 27.63. The current Future 3-5Y EPS without NRI Growth Rate is 27.63 and 33.5% above the Medical Devices & Instruments industry median of 20.70. Autonomix Medical's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Autonomix Medical (AMIX), the current Future 3-5Y EPS without NRI Growth Rate is 27.63 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
15GF Score
Get the complete analysis for AMIX
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMIX has been successfully added to your 
